Literature DB >> 15212815

The toxicity of N-methyl-alpha-methyldopamine to freshly isolated rat hepatocytes is prevented by ascorbic acid and N-acetylcysteine.

Márcia Carvalho1, Fernando Remião, Nuno Milhazes, Fernanda Borges, Eduarda Fernandes, Félix Carvalho, Maria Lourdes Bastos.   

Abstract

In the past decade, clinical evidence has increasingly shown that the liver is a target organ for 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") toxicity. The aims of the present in vitro study were: (1) to evaluate and compare the hepatotoxic effects of MDMA and one of its main metabolites, N-methyl-alpha-methyldopamine (N-Me-alpha-MeDA) and (2) to investigate the ability of antioxidants, namely ascorbic acid and N-acetyl-L-cysteine (NAC), to prevent N-Me-alpha-MeDA-induced toxic injury, using freshly isolated rat hepatocytes. Cell suspensions were incubated with MDMA or N-Me-alpha-MeDA in the final concentrations of 0.1, 0.2, 0.4, 0.8, and 1.6 mM for 3 h. To evaluate the potential protective effects of antioxidants, cells were preincubated with ascorbic acid in the final concentrations of 0.1 and 0.5 mM, or NAC in the final concentrations of 0.1 and 1 mM for 15 min before treatment with 1.6 mM N-Me-alpha-MeDA for 3 h (throughout this incubation period the cells were exposed to both compounds). The toxic effects were evaluated by measuring the cell viability, glutathione (GSH) and glutathione disulfide (GSSG), ATP, and the cellular activities of GSH peroxidase (GPX), GSSG reductase (GR), and GSH S-transferase (GST). MDMA induced a concentration- and time-dependent GSH depletion, but had a negligible effect on cell viability, ATP levels, or on the activities of GR, GPX, and GST. In contrast, N-Me-alpha-MeDA was shown to induce not only a concentration- and time-dependent depletion of GSH, but also a depletion of ATP levels accompanied by a loss in cell viability, and decreases in the antioxidant enzyme activities. For both compounds, GSH depletion was not accompanied by increases in GSSG levels, which seems to indicate GSH depletion by adduct formation. Importantly, the presence of ascorbic acid (0.5 mM) or NAC (1 mM) prevented cell death and GSH depletion induced by N-Me-alpha-MeDA. The results provide evidence that MDMA and its metabolite N-Me-alpha-MeDA induce toxicity to freshly isolated rat hepatocytes. Oxidative stress may play a major role in N-Me-alpha-MeDA-induced hepatic toxicity since antioxidant defense systems are impaired and administration of antioxidants prevented N-Me-alpha-MeDA toxicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15212815     DOI: 10.1016/j.tox.2004.03.016

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  17 in total

Review 1.  Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage.

Authors:  Byoung-Joon Song; Kwan-Hoon Moon; Vijay V Upreti; Natalie D Eddington; Insong J Lee
Journal:  Curr Pharm Biotechnol       Date:  2010-08       Impact factor: 2.837

2.  Acute liver failure following recreational use of psychotropic "head shop" compounds.

Authors:  S Fröhlich; E Lambe; J O'Dea
Journal:  Ir J Med Sci       Date:  2010-11-10       Impact factor: 1.568

3.  Metabolites of MDMA induce oxidative stress and contractile dysfunction in adult rat left ventricular myocytes.

Authors:  Sylvia K Shenouda; Kurt J Varner; Felix Carvalho; Pamela A Lucchesi
Journal:  Cardiovasc Toxicol       Date:  2009-03-31       Impact factor: 3.231

4.  From street to lab: in vitro hepatotoxicity of buphedrone, butylone and 3,4-DMMC.

Authors:  Rita Roque Bravo; Helena Carmo; Maria João Valente; João Pedro Silva; Félix Carvalho; Maria de Lourdes Bastos; Diana Dias da Silva
Journal:  Arch Toxicol       Date:  2021-02-07       Impact factor: 5.153

5.  Effects of endotoxin and catecholamines on hepatic mitochondrial respiration.

Authors:  Francesca Porta; Hendrik Bracht; Christian Weikert; Mario Beck; Jukka Takala; Sebastian Brandt; Luzius B Hiltebrand; Stephan M Jakob
Journal:  Inflammation       Date:  2009-10       Impact factor: 4.092

6.  Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver.

Authors:  Kwan-Hoon Moon; Vijay V Upreti; Li-Rong Yu; Insong J Lee; Xiaoying Ye; Natalie D Eddington; Timothy D Veenstra; Byoung-Joon Song
Journal:  Proteomics       Date:  2008-09       Impact factor: 3.984

7.  Cardiac oxidative stress determination and myocardial morphology after a single ecstasy (MDMA) administration in a rat model.

Authors:  Daniela Cerretani; Irene Riezzo; Anna Ida Fiaschi; Fabio Centini; Giorgio Giorgi; Stefano D'Errico; Carmela Fiore; Steven B Karch; Margherita Neri; Cristoforo Pomara; Emanuela Turillazzi; Vittorio Fineschi
Journal:  Int J Legal Med       Date:  2008-07-02       Impact factor: 2.686

Review 8.  Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.

Authors:  João Paulo Capela; Helena Carmo; Fernando Remião; Maria Lourdes Bastos; Andreas Meisel; Félix Carvalho
Journal:  Mol Neurobiol       Date:  2009-04-17       Impact factor: 5.590

9.  Ecstasy produces left ventricular dysfunction and oxidative stress in rats.

Authors:  Sylvia K Shenouda; Kevin C Lord; Elizabeth McIlwain; Pamela A Lucchesi; Kurt J Varner
Journal:  Cardiovasc Res       Date:  2008-05-20       Impact factor: 10.787

10.  Environmental concentrations of 3,4-methylenedioxymethamphetamine (MDMA)-induced cellular stress and modulated antioxidant enzyme activity in the zebra mussel.

Authors:  Marco Parolini; Stefano Magni; Andrea Binelli
Journal:  Environ Sci Pollut Res Int       Date:  2014-06-01       Impact factor: 4.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.